Evaluation of the therapeutic effect of rTMS on negative symptoms in schizophrenic patients

Effectiveness of repetitive transcranial magnetic stimulation on negative symptoms in schizophrenic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211029052909N1

Enrollment

Registered

2021-12-11

Start date

2022-04-04

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group: Patients were treated with active rTMS. 15 active rTMS sessions with a frequency of 10 Hz, 3 times a week for 5 consecutive weeks. The cap of the device is placed o

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with schizophrenia with negative symptoms Be treated with antipsychotics The patient is in the maintenance phase

Exclusion criteria

Exclusion criteria: Depression Seizure Pregnancy

Design outcomes

Primary

Measure	Time frame
Negative symptoms in schizophrenic patients like poverty of speech, apathy, social withdrawal. Timepoint: One day before starting treatment? One day after the end of treatment, Three weeks after the end of treatment. Method of measurement: The Positive and Negative Syndrome Scale (PANSS).	—

Secondary

Measure	Time frame
Score obtained from Positive and Negative Syndrome Scale. Timepoint: One day before starting treatment?, One day after the end of treatment, Three weeks after the end of treatment. Method of measurement: PANSS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Faghihzadeh

Zanjan University of Medical Sciences

e.faghihzadeh@zums.ac.ir+98 912 608 0676

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026